What is the equity of Silo Pharma this year?
Silo Pharma has equity of 6.18 M USD this year.
Silo Pharma Equity 2024
Silo Pharma Equity
6.18 M USD
Ticker
SILO
ISIN
US82711P2011
In 2024, Silo Pharma's equity was 6.18 M USD, a -40.26% increase from the 10.34 M USD equity in the previous year.
Silo Pharma Aktienanalyse
What does Silo Pharma do?
Silo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Silo Pharma's Equity
Silo Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Silo Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Silo Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Silo Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Silo Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Silo Pharma Stock
What was the equity of Silo Pharma compared to the previous year?
The equity of Silo Pharma has increased/decreased by -40.26% decreased compared to the previous year.
What impact does a high equity have on investors of Silo Pharma?
A high equity is advantageous for investors of Silo Pharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Silo Pharma?
A low equity can be a risk for investors of Silo Pharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Silo Pharma affect the company?
An increase in equity of Silo Pharma can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Silo Pharma affect the company?
A reduction in equity of Silo Pharma can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Silo Pharma?
Some factors that can affect the equity of Silo Pharma include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Silo Pharma so important for investors?
The equity of Silo Pharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Silo Pharma take to change the equity?
To change equity, Silo Pharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Silo Pharma pay?
Over the past 12 months, Silo Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Silo Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Silo Pharma?
The current dividend yield of Silo Pharma is .
When does Silo Pharma pay dividends?
Silo Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Silo Pharma?
Silo Pharma paid dividends every year for the past 0 years.
What is the dividend of Silo Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Silo Pharma located?
Silo Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Silo Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Silo Pharma from 6/14/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/14/2024.
When did Silo Pharma pay the last dividend?
The last dividend was paid out on 6/14/2024.
What was the dividend of Silo Pharma in the year 2023?
In the year 2023, Silo Pharma distributed 0 USD as dividends.
In which currency does Silo Pharma pay out the dividend?
The dividends of Silo Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Silo Pharma
Our stock analysis for Silo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Silo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.